The Everolimus Market is gaining prominence within the pharmaceutical sector as healthcare providers increasingly rely on specialized medicines for complex conditions. Everolimus helps inhibit a cellular signaling pathway associated with growth and proliferation and is used in specific oncology and transplantation settings. The market is anticipated to expand from US$ 1.62 billion in 2025 to...